127 related articles for article (PubMed ID: 21173058)
1. Stability analysis of liver cancer-related microRNAs.
Li Y; Jiang Z; Xu L; Yao H; Guo J; Ding X
Acta Biochim Biophys Sin (Shanghai); 2011 Jan; 43(1):69-78. PubMed ID: 21173058
[TBL] [Abstract][Full Text] [Related]
2. Role of miRNA in carcinogenesis and biomarker selection: a methodological view.
Ahmed FE
Expert Rev Mol Diagn; 2007 Sep; 7(5):569-603. PubMed ID: 17892365
[TBL] [Abstract][Full Text] [Related]
3. Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs.
Wu M; Jolicoeur N; Li Z; Zhang L; Fortin Y; L'Abbe D; Yu Z; Shen SH
Carcinogenesis; 2008 Sep; 29(9):1710-6. PubMed ID: 18356149
[TBL] [Abstract][Full Text] [Related]
4. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.
Li LM; Hu ZB; Zhou ZX; Chen X; Liu FY; Zhang JF; Shen HB; Zhang CY; Zen K
Cancer Res; 2010 Dec; 70(23):9798-807. PubMed ID: 21098710
[TBL] [Abstract][Full Text] [Related]
5. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
[TBL] [Abstract][Full Text] [Related]
6. [miRNAs in cancer: the case of liver tumors].
Ladeiro Y; Zucman-Rossi J
Med Sci (Paris); 2009 May; 25(5):467-72. PubMed ID: 19480827
[TBL] [Abstract][Full Text] [Related]
7. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
Hu X; Macdonald DM; Huettner PC; Feng Z; El Naqa IM; Schwarz JK; Mutch DG; Grigsby PW; Powell SN; Wang X
Gynecol Oncol; 2009 Sep; 114(3):457-64. PubMed ID: 19501389
[TBL] [Abstract][Full Text] [Related]
8. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform.
Resnick KE; Alder H; Hagan JP; Richardson DL; Croce CM; Cohn DE
Gynecol Oncol; 2009 Jan; 112(1):55-9. PubMed ID: 18954897
[TBL] [Abstract][Full Text] [Related]
9. Instability of miRNA and cDNAs derivatives in RNA preparations.
Bravo V; Rosero S; Ricordi C; Pastori RL
Biochem Biophys Res Commun; 2007 Feb; 353(4):1052-5. PubMed ID: 17204243
[TBL] [Abstract][Full Text] [Related]
10. A high-throughput method to monitor the expression of microRNA precursors.
Schmittgen TD; Jiang J; Liu Q; Yang L
Nucleic Acids Res; 2004 Feb; 32(4):e43. PubMed ID: 14985473
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers.
Zen K; Zhang CY
Med Res Rev; 2012 Mar; 32(2):326-48. PubMed ID: 22383180
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA isolation and stability in stored RNA samples.
Mraz M; Malinova K; Mayer J; Pospisilova S
Biochem Biophys Res Commun; 2009 Dec; 390(1):1-4. PubMed ID: 19769940
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in breast cancer pathogenesis.
Götte M
Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.
Yamamoto Y; Kosaka N; Tanaka M; Koizumi F; Kanai Y; Mizutani T; Murakami Y; Kuroda M; Miyajima A; Kato T; Ochiya T
Biomarkers; 2009 Nov; 14(7):529-38. PubMed ID: 19863192
[TBL] [Abstract][Full Text] [Related]
15. miRNAs in cancer: approaches, aetiology, diagnostics and therapy.
Blenkiron C; Miska EA
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R106-13. PubMed ID: 17613543
[TBL] [Abstract][Full Text] [Related]
16. Use of serum-circulating miRNA profiling for the identification of breast cancer biomarkers.
Mar-Aguilar F; Rodríguez-Padilla C; Reséndez-Pérez D
Methods Mol Biol; 2014; 1165():71-80. PubMed ID: 24839019
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets.
Meyer-Rochow GY; Jackson NE; Conaglen JV; Whittle DE; Kunnimalaiyaan M; Chen H; Westin G; Sandgren J; Stålberg P; Khanafshar E; Shibru D; Duh QY; Clark OH; Kebebew E; Gill AJ; Clifton-Bligh R; Robinson BG; Benn DE; Sidhu SB
Endocr Relat Cancer; 2010 Sep; 17(3):835-46. PubMed ID: 20621999
[TBL] [Abstract][Full Text] [Related]
19. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.
Xi Y; Shalgi R; Fodstad O; Pilpel Y; Ju J
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2014-24. PubMed ID: 16609010
[TBL] [Abstract][Full Text] [Related]
20. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases.
Weiland M; Gao XH; Zhou L; Mi QS
RNA Biol; 2012 Jun; 9(6):850-9. PubMed ID: 22699556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
